Publications

Publications

Academic Publications

1. Kaur, Harpreet, et al. "Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder." Psychedelic Medicine (2023)

2. Karabulut, Sedat, Harpreet Kaur, and James W. Gauld. "Applications and Potential of In Silico Approaches for Psychedelic Chemistry." Molecules 28.16 (2023): 5966.

Patents

1. US2023/0201159 A1, assignee: PharmAla Biotech, inventors: Kadysh N, Howell L, Kaur H 

- Full text here: https://patentimages.storage.googleapis.com/56/21/82/e4a8cf3943e7b1/US20230201159A1.pdf

2. WO2022232949A1 

- Full text here: https://patents.google.com/patent/WO2022232949A1/en?oq=WO2022232949A1

Conferences

Invited Talks:

1. Harpreet Kaur, Psychedelics as Therapeutics, Bass Coast 2022

2. Harpreet Kaur, Psychedelics: Safety Considerations, Bass Coast 2023

3. Harpreet Kaur, Career in Psychedelics after academia, University of Arkansas for Medical Sciences, 2023, upcoming

Invited Panel Discussions:

1. Philippe Lucas, Danny Motkya, Spencer Hawkswell, Harpreet Kaur “The Future of Psychedelic Use and Research in Canada”, Grow Up Victoria, Canada, June 20-22, 2022

2. Tom McDonald, Clare Knight, James Lanthier, Harpreet Kaur: “Overcoming the Complexities of Psychedelic Trials”, 3rd Annual Psychedelic Therapeutics and Drug Development Conference, San Francisco, May 23-24, 2023

Poster Presentations:

1. Holloway KH, Shaw HE; Kaur H, and Fantegrossi WE, Cardiovascular effects of methamphetamine, 3,4-methylenedioxymethamphetamine, and other entactogens in C57BL/6 and BTBR T+ Itpr3tf/J mice.(2023) 15th Annual Behavior, Biology and Chemistry: Translational Research in Substance Use Disorders

2. Bierbaum CG , Shaw HE ; Kaur H and Fantegrossi WE, Effects of S-methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers on place conditioning in C57BL/6 and BTBR T+ Itpr3tf/J mice. (2023) 15th Annual Behavior, Biology and Chemistry: Translational Research in Substance Use Disorders

3. Fagot SA, Shaw HE; Kaur H and Fantegrossi WE. Thermoregulatory and locomotor effects of 3,4-methylenedioxy-methamphetamine (MDMA), its enantiomers, and a non-racemic mixture.(2023) 15th Annual Behavior, Biology and Chemistry: Translational Research in Substance Use Disorders